Physician profile
Daniel Sheldon
NPI 1043834336
$423.40
in general payments reported to CMS, 2019-2025
10 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.67 · 2023: $17.56 · 2024: $190 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $133.21 | 2025 | Terlivaz |
| La Jolla Pharmaceutical Company | $133.17 | 2024 | Giapreza |
| Mindray Ds USA, INC. | $26.11 | 2025 | Te X, Te7 Max |
| Verona Pharma, INC. | $25.25 | 2025 | Ohtuvayre |
| Teleflex LLC | $22.89 | 2024 | Arrow |
| Shionogi INC | $18.94 | 2025 | Fetroja |
| Smith+Nephew, INC. | $17.83 | 2024 | Collagenase Santyl |
| Ethicon US, LLC | $17.56 | 2023 | Echelon; Endopath, Surgicel Nu-Knit |
| Janssen Pharmaceuticals, INC | $15.77 | 2024 | Xarelto |
| Ucb, INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sheldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.